UBS Maintains Buy on Encompass Health, Raises Price Target to $155

Benzinga Newsdesk www.benzinga.com Positive 75.5%

Neg 0% Neu 0% Pos 75.5%

UBS analyst A.J. Rice maintains Encompass Health (NYSE:EHC) with a Buy and raises the price target from $150 to $155.

Comments

No comments yet. Be the first!